{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:45:02Z","timestamp":1759333502168},"reference-count":83,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2002]]},"DOI":"10.1080\/00313020120105615","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T15:23:56Z","timestamp":1027697036000},"page":"36-45","source":"Crossref","is-referenced-by-count":12,"title":["Cutaneous lymphomas: which pathological classification?"],"prefix":"10.1016","volume":"34","author":[{"given":"H.","family":"Miles Prince","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rod","family":"O\u2019Keefe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Mccormack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugh","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Waring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1080\/00313020120105615_bib0005","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1200\/JCO.2000.18.10.2152","article-title":"Primary cutaneous B-cell lymphoma: review and current concepts","volume":"18","author":"Pandolfino","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1080\/00313020120105615_bib0010","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1182\/blood.V88.7.2385.bloodjournal8872385","article-title":"Mycosis fungoides and Sezary syndrome","volume":"88","author":"Diamandidou","year":"1996","journal-title":"Blood"},{"key":"10.1080\/00313020120105615_bib0015","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1200\/JCO.2000.18.15.2908","article-title":"Primary cutaneous T-cell lymphoma: Review and current concepts","volume":"18","author":"Siegel","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1080\/00313020120105615_bib0020","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1200\/JCO.2001.19.16.3602","article-title":"Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study","volume":"19","author":"Bekkenk","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1080\/00313020120105615_bib0025","series-title":"World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","year":"2001"},{"issue":"Suppl","key":"10.1080\/00313020120105615_bib0030","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1111\/j.1440-0960.1997.tb01018.x","article-title":"Mycosis fungoides: An Australian experience","volume":"58","author":"Yen","year":"1997","journal-title":"Aust J Dermatol"},{"issue":"Suppl 1","key":"10.1080\/00313020120105615_bib0035","first-page":"S13","article-title":"The usefulness of immunophenotypic and genotypic studies in the diagnosis and classification of hematopoietic and lymphoid neoplasms","volume":"111","author":"Frizzera","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.1080\/00313020120105615_bib0040","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/00000478-199707000-00001","article-title":"The value of the polymerase chain reaction in the diagnosis of cutaneous T-cell infiltrates","volume":"21","author":"Ashton-Key","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1080\/00313020120105615_bib0045","first-page":"498","article-title":"How useful are T-cell receptor gene rearrangement studies as an adjunct to the histopathologic diagnosis of mycosis fungoides","volume":"21","author":"Bergman","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.1080\/00313020120105615_bib0050","first-page":"543","article-title":"A revised European-American classification of lymphoid neoplasms proposed by the International Lymphoma Study Group: a summary version","volume":"3","author":"Chan","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1080\/00313020120105615_bib0055","first-page":"354","article-title":"EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma study group of the European Organization for Research and Treatment of Cancer","volume":"90","author":"Willemze","year":"1997","journal-title":"Blood"},{"key":"10.1080\/00313020120105615_bib0060","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","article-title":"The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: Report of the clinical advisory committee meeting \u2013 Airlie House, Virginia, November, 1997","volume":"17","author":"Harris","year":"1999","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"10.1080\/00313020120105615_bib0065","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1093\/annonc\/11.suppl_1.S11","article-title":"EORTC classification for primary cutaneous lymphomas: a comparison with the R.E.A.L. classification and the proposed WHO classification","volume":"11","author":"Willemze","year":"2000","journal-title":"Ann Oncol"},{"issue":"Suppl 1","key":"10.1080\/00313020120105615_bib0070","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1093\/annonc\/11.suppl_1.S17","article-title":"Cutaneous lymphomas: a proposal for a unified approach to classification using the R.E.A.L.\/WHO classification","volume":"11","author":"Jaffe","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1080\/00313020120105615_bib0075","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1365-2559.1994.tb01371.x","article-title":"A proposal for classification of lymphoid neoplasms (by the International Lymphoma Study Group)","volume":"25","author":"Chan","year":"1994","journal-title":"Histopathology"},{"key":"10.1080\/00313020120105615_bib0080","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1600-0560.1997.tb00801.x","article-title":"The Revised European-American Classification of Lymphoid Neoplasms (REAL): a new perspective for the classification of cutaneous lymphomas","volume":"24","author":"Sander","year":"1997","journal-title":"J Cutan Pathol"},{"key":"10.1080\/00313020120105615_bib0085","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/00000372-199912000-00015","article-title":"Primary cutaneous lymphomas?","volume":"21","author":"Cerroni","year":"1999","journal-title":"Am J Dermatopathol"},{"key":"10.1080\/00313020120105615_bib0090","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00000372-200008000-00012","article-title":"Primary or primarily?","volume":"22","author":"Ackerman","year":"2000","journal-title":"Am J Dermatopathol"},{"key":"10.1080\/00313020120105615_bib0095","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1200\/JCO.2001.19.3.779","article-title":"Clinical characteristics and outcome of patients with extracutaneous mycosis fungoides","volume":"19","author":"de Coninck","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1080\/00313020120105615_bib0100","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1200\/JCO.2001.19.2.398","article-title":"Primary cutaneous non-Hodgkin\u2019s lymphoma of Ann Arbor stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapy","volume":"19","author":"Sarris","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1080\/00313020120105615_bib0105","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00000478-199407000-00001","article-title":"The histologic spectrum of mycosis fungoides\/Sezary syndrome (cutaneous T-cell lymphoma)","volume":"18","author":"Shapiro","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"10.1080\/00313020120105615_bib0110","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1097\/00000478-199512000-00009","article-title":"Reassessment of histologic parameters in the diagnosis of mycosis fungoides","volume":"19","author":"Smoller","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1080\/00313020120105615_bib0115","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00000478-200001000-00005","article-title":"Efficacy of histologic criteria for diagnosing early mycosis fungoides","volume":"24","author":"Santucci","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1080\/00313020120105615_bib0120","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1182\/blood.V92.4.1150","article-title":"Transformation of mycosis fungoides\/Sezary syndrome: clinical characteristics and prognosis","volume":"92","author":"Diamandidou","year":"1998","journal-title":"Blood"},{"key":"10.1080\/00313020120105615_bib0125","first-page":"2212","article-title":"Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases","volume":"95","author":"Vergier","year":"2000","journal-title":"Blood"},{"key":"10.1080\/00313020120105615_bib0130","series-title":"An Illustrated Guide to Skin Lymphoma","year":"1998"},{"key":"10.1080\/00313020120105615_bib0135","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/00000372-199704000-00003","article-title":"Persistent pigmented purpuric dermatitis and mycosis fungoides: simulant, precursor, or both","volume":"19","author":"Toro","year":"1997","journal-title":"Am J Dermatopath"},{"key":"10.1080\/00313020120105615_bib0140","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1023\/A:1008397323199","article-title":"Prognostic factors in Sezary syndrome: a multivariate analysis of clinical, haematological and immunological features","volume":"9","author":"Bernengo","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1080\/00313020120105615_bib0145","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1001\/archderm.1991.01680090075007","article-title":"Prognostic clinicopathologic factors in cutaneous T-cell lymphoma","volume":"127","author":"Marti","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1080\/00313020120105615_bib0150","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1034\/j.1600-0609.2000.9c119.x","article-title":"Deafness from eighth cranial nerve involvement in a patient with large-cell transformation of mycosis fungoides","volume":"64","author":"Chua","year":"2000","journal-title":"Eur J Haematol"},{"key":"10.1080\/00313020120105615_bib0155","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1056\/NEJM198912283212603","article-title":"A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides","volume":"321","author":"Kaye","year":"1989","journal-title":"New Engl J Med"},{"key":"10.1080\/00313020120105615_bib0160","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/archderm.134.8.949","article-title":"Topical corticosteroids for mycosis fungoides","volume":"134","author":"Zackheim","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1080\/00313020120105615_bib0165","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0190-9622(95)90241-4","article-title":"Treatment of mycosis fungoides with photochemotherapy (PUVA); long-term follow-up","volume":"33","author":"Herrmann","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1080\/00313020120105615_bib0170","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/archderm.135.11.1377","article-title":"Narrowband (311-nm) UV-B therapy for small plaque parapsoriasis and early-stage mycosis fungoides","volume":"135","author":"Hofer","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1080\/00313020120105615_bib0175","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/1097-0142(19831215)52:12<2214::AID-CNCR2820521207>3.0.CO;2-H","article-title":"Ointment-based mechlorethamine treatment for mycosis fungoides","volume":"52","author":"Price","year":"1983","journal-title":"Cancer"},{"key":"10.1080\/00313020120105615_bib0180","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1200\/JCO.2001.19.9.2456","article-title":"Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II\u2013III trial results","volume":"19","author":"Duvic","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1080\/00313020120105615_bib0185","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1440-0960.2001.00488.x","article-title":"Bexarotene capsules and gel for previously treated patients with cutaneous T-cell lymphoma: results of the Australian patients treated on phase II trials","volume":"42","author":"Prince","year":"2001","journal-title":"Aust J Dermatol"},{"key":"10.1080\/00313020120105615_bib0190","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/1097-0142(19860415)57:8+<1689::AID-CNCR2820571311>3.0.CO;2-M","article-title":"The role of recombinant interferon alfa-2a in the therapy of cutaneous T-cell lymphomas","volume":"57","author":"Bunn","year":"1986","journal-title":"Cancer"},{"key":"10.1080\/00313020120105615_bib0195","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0190-9622(89)70049-9","article-title":"Interferon alfa-2a in the treatment of cutaneous T-cell lymphoma","volume":"20","author":"Olsen","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1080\/00313020120105615_bib0200","first-page":"1","article-title":"Photophoresis update","volume":"25","author":"Edelson","year":"1991","journal-title":"Prog Dermatol"},{"key":"10.1080\/00313020120105615_bib0205","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/archderm.134.8.1001","article-title":"Extracorporeal photophoresis in Sezary syndrome: no significant effect in the survival of 44 patients with peripheral blood T-cell clone","volume":"134","author":"Fraser-Andrews","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1080\/00313020120105615_bib0210","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1200\/JCO.2001.19.2.376","article-title":"Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma","volume":"19","author":"Olsen","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1080\/00313020120105615_bib0215","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1182\/blood.V94.3.902.415k23_902_908","article-title":"Interleukin-12 therapy of cutaneous T-cell lymphoma induces lesion regression and cytotoxic T-cell responses","volume":"94","author":"Rook","year":"1999","journal-title":"Blood"},{"key":"10.1080\/00313020120105615_bib0220","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0889-8588(18)30052-2","article-title":"Epidemiology and clinical manifestations of cutaneous T-cell lymphoma","volume":"9","author":"Koh","year":"1995","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1080\/00313020120105615_bib0225","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1182\/blood.V69.3.841.841","article-title":"Evaluation of circulating malignant cells provides prognostic information in cutaneous T-cell lymphoma","volume":"69","author":"Schecter","year":"1987","journal-title":"Blood"},{"key":"10.1080\/00313020120105615_bib0230","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0190-9622(90)70054-L","article-title":"Sezary syndrome: diagnosis, prognosis, and critical review of treatment options","volume":"22","author":"Wieselthier","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1080\/00313020120105615_bib0235","first-page":"3637","article-title":"Prognostic factors in primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome","volume":"93","author":"Grange","year":"1999","journal-title":"Blood"},{"key":"10.1080\/00313020120105615_bib0240","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1023\/A:1008414002612","article-title":"Peripheral T-cell lymphoma: a developing concept","volume":"9","author":"Pileri","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1080\/00313020120105615_bib0245","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1182\/blood.V91.6.2076","article-title":"ALK-positive lymphoma: a single disease with a broad spectrum of morphology","volume":"91","author":"Benharroch","year":"1998","journal-title":"Blood"},{"key":"10.1080\/00313020120105615_bib0250","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00125480-199809000-00002","article-title":"Anaplastic large cell lymphoma: redefining its morphologic spectrum and importance of recognition of the ALK-positive subset","volume":"5","author":"Chan","year":"1998","journal-title":"Adv Anat Pathol"},{"key":"10.1080\/00313020120105615_bib0255","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood.V95.12.3653","article-title":"Primary and secondary cutaneous CD30 + lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment","volume":"95","author":"Bekkenk","year":"2000","journal-title":"Blood"},{"key":"10.1080\/00313020120105615_bib0260","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1182\/blood.V90.9.3727","article-title":"Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome","volume":"90","author":"Tilly","year":"1997","journal-title":"Blood"},{"key":"10.1080\/00313020120105615_bib0265","first-page":"1169","article-title":"Primary and secondary Ki-1+ (CD30 +) anaplastic large cell lymphoma","volume":"135","author":"Kaudewitz","year":"1989","journal-title":"Am J Pathol"},{"key":"10.1080\/00313020120105615_bib0270","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/00000478-199807000-00010","article-title":"Subcutaneous pannicultitislike T-cell lymphoma","volume":"22","author":"Salhany","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1080\/00313020120105615_bib0275","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/00000478-199905000-00012","article-title":"Aggressive cutaneous NK and NK-like T-cell lymphomas","volume":"23","author":"Natkunam","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.1080\/00313020120105615_bib0280","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1046\/j.1365-2133.2000.03472.x","article-title":"Clinicopathological features of CD56+ nasal-type T\/natural killer cell lymphomas with lobular panniculitis","volume":"142","author":"Chang","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1080\/00313020120105615_bib0285","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1046\/j.1365-2133.2000.03490.x","article-title":"Nasal and nasal type CD56 + natural killer cell\/T-cell lymphoma: a case with rapid progression to bone marrow involvement","volume":"142","author":"Ahn","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1080\/00313020120105615_bib0290","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1046\/j.1365-2133.2000.03527.x","article-title":"Cutaneous CD56 natural killer and natural killer-like T-cell lymphoma","volume":"142","author":"Slater","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1080\/00313020120105615_bib0295","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0046-8177(99)90219-8","article-title":"Cases of cutaneous and nasal CD56 (NCAM)-positive lymphoma in Japan have differences in immunohistology, genotype, and etiology","volume":"30","author":"Takeshita","year":"1999","journal-title":"Hum Pathol"},{"issue":"Suppl 1","key":"10.1080\/00313020120105615_bib0300","first-page":"S104","article-title":"The role of morphologic features, phenotype, genotype, and anatomic site in defining extranodal T-cell or NK-cell neoplasms","volume":"111","author":"Kinney","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.1080\/00313020120105615_bib0305","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1200\/JCO.1998.16.1.70","article-title":"Primary non-Hodgkin\u2019s lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients","volume":"16","author":"Cheung","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1080\/00313020120105615_bib0310","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1182\/blood.V87.4.1207.bloodjournal8741207","article-title":"Classification of Natural Killer (NK) cell and NK-like T-cell malignancies","volume":"87","author":"Jaffe","year":"1996","journal-title":"Blood"},{"key":"10.1080\/00313020120105615_bib0315","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0046-8177(99)90266-6","article-title":"Analysis of clonality of atypical cutaneous lymphoid infiltrates associated with drug therapy by PCR\/DGGE","volume":"30","author":"Brady","year":"1999","journal-title":"Hum Pathol"},{"key":"10.1080\/00313020120105615_bib0320","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/00000372-199912000-00003","article-title":"Solitary skin lesions with histopathologic features of early mycosis fungoides","volume":"21","author":"Cerroni","year":"1999","journal-title":"Am J Dermatopathol"},{"key":"10.1080\/00313020120105615_bib0325","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2133.1988.tb02465.x","article-title":"Drug-induced pseudolympho -matous skin reactions","volume":"118","author":"Khardoun","year":"1988","journal-title":"Br J Dermatol"},{"issue":"Suppl 1","key":"10.1080\/00313020120105615_bib0330","first-page":"S84","article-title":"Approach to lymphoproliferative infiltrates of the skin","volume":"111","author":"Kempf","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.1080\/00313020120105615_bib0335","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2133.1994.tb08560.x","article-title":"MALT and SALT: the clue to cutaneous B-cell lymphoproliferative disease","volume":"131","author":"Slater","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1080\/00313020120105615_bib0340","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/path.1711720403","article-title":"Cutaneous B-cell lymphoproliferative diseases: a centenary celebration classification","volume":"172","author":"Slater","year":"1994","journal-title":"J Pathol"},{"key":"10.1080\/00313020120105615_bib0345","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00000478-199901000-00010","article-title":"Cutaneous lymphoid hyperplasia and cutaneous marginal zone lymphoma","volume":"23","author":"Baldassano","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.1080\/00313020120105615_bib0350","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1097\/00000478-199711000-00012","article-title":"Are primary cutaneous immunocytoma and marginal zone lymphoma the same disease?","volume":"21","author":"Duncan","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1080\/00313020120105615_bib0355","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/00000478-199706000-00019","article-title":"Marginal zone lymphoma of skin","volume":"21","author":"Slater","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1080\/00313020120105615_bib0360","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1182\/blood.V95.12.3922","article-title":"Primary cutaneous follicle center cell lymphoma with follicular growth pattern","volume":"95","author":"Cerroni","year":"2000","journal-title":"Blood"},{"key":"10.1080\/00313020120105615_bib0365","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/00000478-200005000-00008","article-title":"Clinicopathologic reassessment of primary cutaneous B-cell lymphomas with immunophenotypic and molecular genetic characterization","volume":"24","author":"Yang","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1080\/00313020120105615_bib0370","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1200\/JCO.1999.17.8.2471","article-title":"Treatment of multifocal primary cutaneous B-cell lymphoma: a clinical follow-up study of 29 patients","volume":"7","author":"Bekkenk","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1080\/00313020120105615_bib0375","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1040-0486(97)80009-9","article-title":"Cutaneous lymphomas","volume":"9","author":"Burg","year":"1997","journal-title":"Curr Probl Dermatol"},{"key":"10.1080\/00313020120105615_bib0380","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJM199803193381205","article-title":"Molecular analysis of the progression from Helicobacter pylori-associated chronic gastritis to mucosa-associated lymphoid tissue lymphoma of the stomach","volume":"338","author":"Zucca","year":"1998","journal-title":"New Engl J Med"},{"key":"10.1080\/00313020120105615_bib0385","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/00000478-200009000-00012","article-title":"Primary cutaneous B-cell lymphoma and Borrelia burgdorferi infection in patients from the highlands of Scotland","volume":"24","author":"Goodlad","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1080\/00313020120105615_bib0390","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1023\/A:1008278725106","article-title":"Nongastrointestinal mucosa-associated lymphoid tissue (MALT) lymphomas: clinical and therapeutic features of 24 localized patients","volume":"8","author":"Zinzani","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1080\/00313020120105615_bib0395","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1200\/JCO.1999.17.8.2486","article-title":"Marginal zone B-cell lymphoma: a clinical comparison of nodal and mucosa-associated lymphoid tissue types","volume":"17","author":"Nathwani","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1080\/00313020120105615_bib0400","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/00000478-199410000-00001","article-title":"Primary cutaneous immunocytoma","volume":"18","author":"LeBoit","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"10.1080\/00313020120105615_bib0405","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/00000478-199608000-00010","article-title":"Marginal zone lymphoma (low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type) of skin and subcutaneous tissue","volume":"20","author":"Bailey","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1080\/00313020120105615_bib0410","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/00000478-199711000-00005","article-title":"Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma","volume":"21","author":"Cerroni","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1080\/00313020120105615_bib0415","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00000372-200006000-00001","article-title":"Extranodal marginal zone B-cell lymphoma of the skin: a morphologic and immunophenotypic study of 11 cases","volume":"22","author":"Tomaszewski","year":"2000","journal-title":"Am J Dermatopathol"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516345202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516345202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T21:21:05Z","timestamp":1583270465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302516345202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002]]},"references-count":83,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002]]}},"alternative-id":["S0031302516345202"],"URL":"https:\/\/doi.org\/10.1080\/00313020120105615","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2002]]}}}